Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B
The Turkish Journal of Gastroenterology · 2014
DOI: 10.5152/tjg.2014.0005 ↗Kurz gefasst
Kommentar in der Zeitschrift The Turkish Journal of Gastroenterology, 2014. Verfasst von Seyfettin Köklü. Beteiligte Einrichtung: Department of Gastroenterology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis B, Chronic, Liver Neoplasms, Patient Acuity.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Zitieren
APA
Köklü, S. (2014). Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B. The Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2014.0005
Vancouver
Köklü S. Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B. The Turkish Journal of Gastroenterology. 2014. doi:10.5152/tjg.2014.0005
BibTeX
@article{Kkl2014,
author = {Köklü, Seyfettin},
title = {Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis B},
journal = {The Turkish Journal of Gastroenterology},
year = {2014},
doi = {10.5152/tjg.2014.0005}
}
EUVIMED